# DLBS2411 Treatment For Functional Dyspepsia

> **NCT05248802** · PHASE3 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 106 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Placebo caplet of DLBS2411
- **DRUG:** DLBS2411

## Key facts

- **NCT ID:** NCT05248802
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-09
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05248802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05248802, "DLBS2411 Treatment For Functional Dyspepsia". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT05248802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*